These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23269222)

  • 1. Nesfatin-1 in advanced lung cancer patients with weight loss.
    Cetinkaya H; Karagöz B; Bilgi O; Ozgün A; Tunçel T; Emirzeoğlu L; Top C; Kandemir EG
    Regul Pept; 2013 Feb; 181():1-3. PubMed ID: 23269222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The newly identified anorexigenic adipokine nesfatin-1 in hemodialysis patients: Are there associations with food intake, body composition and inflammation?
    Saldanha JF; Carrero JJ; Lobo JC; Stockler-Pinto MB; Leal VO; Calixto A; Geloneze B; Mafra D
    Regul Pept; 2012 Jan; 173(1-3):82-5. PubMed ID: 22036920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased serum levels of ghrelin at diagnosis mediate body weight loss in non-small cell lung cancer (NSCLC) patients.
    Karapanagiotou EM; Polyzos A; Dilana KD; Gratsias I; Boura P; Gkiozos I; Syrigos KN
    Lung Cancer; 2009 Dec; 66(3):393-8. PubMed ID: 19282046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of nesfatin-1 and fat mass in cystic fibrosis.
    Cohen RI; Ginsberg N; Tsang D; Wann LC; Ye X; Liu SF
    Respiration; 2013; 86(4):312-7. PubMed ID: 23306670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of serum levels of nesfatin-1 in children and adolescents with autoimmune thyroid diseases].
    Sawicka B; Bossowski A
    Pediatr Endocrinol Diabetes Metab; 2013; 19(1):5-10. PubMed ID: 23739643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteopontin as a marker of weight loss in lung cancer.
    Karadag F; Gulen ST; Karul AB; Kilicarslan N; Ceylan E; Kuman NK; Cildag O
    Scand J Clin Lab Invest; 2011 Dec; 71(8):690-4. PubMed ID: 22017168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel appetite peptide, nesfatin-1 in patients with non-alcoholic fatty liver disease.
    Başar O; Akbal E; Köklü S; Koçak E; Tuna Y; Ekiz F; Gültuna S; Yιlmaz FM; Aydoğan T
    Scand J Clin Lab Invest; 2012 Oct; 72(6):479-83. PubMed ID: 22950627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-cachexia in patients with stages I-III non-small cell lung cancer: systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome system.
    Op den Kamp CM; Langen RC; Minnaard R; Kelders MC; Snepvangers FJ; Hesselink MK; Dingemans AC; Schols AM
    Lung Cancer; 2012 Apr; 76(1):112-7. PubMed ID: 22018880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum nesfatin-1 levels in overt and subclinical hyperthyroidism.
    Gungunes A; Ozbek M; Ginis Z; Sahin M; Demirci T; Cakir Ozkaya E; Karbek B; Sayki Arslan M; Ozturk Unsal I; Tutal Akkaya E; Ucan B; Gultuna Ozguclu S; Cakal E; Topaloglu O; Delibasi T
    Minerva Endocrinol; 2014 Sep; 39(3):209-14. PubMed ID: 25068306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentrations of prealbumin and some appetite-controlling hormones in pregnancies associated with hyperemesis gravidarium.
    Ozturk G; Ozgu-Erdinc AS; Ucar F; Ginis Z; Erden G; Danisman N
    Ann Clin Biochem; 2017 Mar; 54(2):258-263. PubMed ID: 27235705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased serum nesfatin-1 levels in endometriosis.
    Şengül Ö; Dilbaz B; Halıcı Z; Ferah I; Çadırcı E; Yılmaz F
    Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():34-7. PubMed ID: 24702902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased plasma levels of nesfatin-1 in patients with newly diagnosed type 2 diabetes mellitus.
    Zhang Z; Li L; Yang M; Liu H; Boden G; Yang G
    Exp Clin Endocrinol Diabetes; 2012 Feb; 120(2):91-5. PubMed ID: 22020667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MCG101-induced cancer anorexia-cachexia features altered expression of hypothalamic Nucb2 and Cartpt and increased plasma levels of cocaine- and amphetamine-regulated transcript peptides.
    Burgos JR; Iresjö BM; Smedh U
    Oncol Rep; 2016 Apr; 35(4):2425-30. PubMed ID: 26780979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased plasma nesfatin-1 levels in patients with generalized anxiety disorder.
    Gunay H; Tutuncu R; Aydin S; Dag E; Abasli D
    Psychoneuroendocrinology; 2012 Dec; 37(12):1949-53. PubMed ID: 22595767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of TNF-alpha and IL-6 levels on development of cachexia in newly diagnosed NSCLC patients.
    Kayacan O; Karnak D; Beder S; Güllü E; Tutkak H; Senler FC; Köksal D
    Am J Clin Oncol; 2006 Aug; 29(4):328-35. PubMed ID: 16891858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ghrelins, obestatin, nesfatin-1 and leptin levels in pregnant women with and without hyperemesis gravidarum.
    Gungor S; Gurates B; Aydin S; Sahin I; Kavak SB; Kumru S; Celik H; Aksoy A; Yilmaz M; Catak Z; Citil C; Baykus Y; Deniz R; Karakaya F; Özdemir N
    Clin Biochem; 2013 Jun; 46(9):828-30. PubMed ID: 23380589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NUCB2/nesfatin-1 is associated with elevated scores of anxiety in female obese patients.
    Hofmann T; Stengel A; Ahnis A; Buße P; Elbelt U; Klapp BF
    Psychoneuroendocrinology; 2013 Nov; 38(11):2502-10. PubMed ID: 23796625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The significance of leptin, adiponectin, and resistin serum levels in non-small cell lung cancer (NSCLC).
    Karapanagiotou EM; Tsochatzis EA; Dilana KD; Tourkantonis I; Gratsias I; Syrigos KN
    Lung Cancer; 2008 Sep; 61(3):391-7. PubMed ID: 18342391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Leptin serum levels in cachectic and non-cachectic lung cancer patients].
    Weryńska B; Kosacka M; Gołecki M; Jankowska R
    Pneumonol Alergol Pol; 2009; 77(6):500-6. PubMed ID: 20013699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrimination of clinical stages in non-small cell lung cancer patients by serum HSP27 and HSP70: a multi-institutional case-control study.
    Zimmermann M; Nickl S; Lambers C; Hacker S; Mitterbauer A; Hoetzenecker K; Rozsas A; Ostoros G; Laszlo V; Hofbauer H; Renyi-Vamos F; Klepetko W; Dome B; Ankersmit HJ
    Clin Chim Acta; 2012 Jul; 413(13-14):1115-20. PubMed ID: 22465083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.